CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
Phone203-488-6056
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$21.92 million
Profitability
Miscellaneous
Employees76
Next Earnings Date5/9/2019 (Estimated)
OptionableNot Optionable
CAS Medical Systems (NASDAQ:CASM) Frequently Asked Questions
What is CAS Medical Systems' stock symbol?
CAS Medical Systems trades on the NASDAQ under the ticker symbol "CASM."
How were CAS Medical Systems' earnings last quarter?
CAS Medical Systems Inc (NASDAQ:CASM) released its earnings results on Wednesday, October, 31st. The medical technology company reported ($0.06) earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of ($0.07) by $0.01. The medical technology company had revenue of $5.38 million for the quarter, compared to analysts' expectations of $5.23 million. View CAS Medical Systems' Earnings History.
When is CAS Medical Systems' next earnings date?
What is the consensus analysts' recommendation for CAS Medical Systems?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CAS Medical Systems in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for CAS Medical Systems.
Has CAS Medical Systems been receiving favorable news coverage?
Media stories about CASM stock have trended somewhat negative on Tuesday, InfoTrie Sentiment reports. The research firm identifies positive and negative news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. CAS Medical Systems earned a news impact score of -1.6 on InfoTrie's scale. They also assigned media stories about the medical technology company a news buzz of 5.0 out of 10, indicating that recent news coverage is somewhat likely to have an effect on the company's share price in the immediate future.
Who are some of CAS Medical Systems' key competitors?
Some companies that are related to CAS Medical Systems include Neuronetics (STIM), SeaSpine (SPNE), Cytosorbents (CTSO), Nuvectra (NVTR), Liquidia Technologies (LQDA), Apyx Medical (APYX), RenovaCare (RCAR), Alphatec (ATEC), T2 Biosystems (TTOO), Sensus Healthcare (SRTS), STRATA Skin Sciences (SSKN), Motus GI (MOTS), iCAD (ICAD), Apollo Endosurgery (APEN) and Spectral Medical (EDTXF).
What other stocks do shareholders of CAS Medical Systems own?
Who are CAS Medical Systems' key executives?
CAS Medical Systems' management team includes the folowing people:
- Mr. Thomas M. Patton, Pres, CEO & Director (Age 55)
- Mr. Jeffery A. Baird, CFO & Sec. (Age 65)
- Mr. John K. Gamelin, VP of R&D (Age 54)
- Dr. Paul B. Benni, Chief Scientific Officer (Age 51)
- Susan Carron, Director of Corp. Communications
Who are CAS Medical Systems' major shareholders?
Which institutional investors are selling CAS Medical Systems stock?
Which institutional investors are buying CAS Medical Systems stock?
How do I buy shares of CAS Medical Systems?
Shares of CASM can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CAS Medical Systems' stock price today?
One share of CASM stock can currently be purchased for approximately $2.45.
How big of a company is CAS Medical Systems?
CAS Medical Systems has a market capitalization of $71.88 million and generates $21.92 million in revenue each year. The medical technology company earns $-5,960,000.00 in net income (profit) each year or ($0.27) on an earnings per share basis. CAS Medical Systems employs 76 workers across the globe.
What is CAS Medical Systems' official website?
How can I contact CAS Medical Systems?
CAS Medical Systems' mailing address is 44 East Industrial Road, Branford CT, 06405. The medical technology company can be reached via phone at 203-488-6056 or via email at [email protected]
MarketBeat Community Rating for CAS Medical Systems (NASDAQ CASM)
MarketBeat's community ratings are surveys of what our community members think about CAS Medical Systems and other stocks. Vote "Outperform" if you believe CASM will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CASM will underperform the S&P 500 over the long term. You may vote once every thirty days.
